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History of the International Association for the Study of
Lung Cancer
In October 1972, the First International Workshop for Ther-apy of Lung Cancer was held at Airlie House Conference
Center outside Washington D.C. This conference, sponsored
by the National Cancer Institute, drew together exchange of
ideas among this multi-disciplinary international group was
both productive and stimulating. At the concluding meeting,
held on October 20, 1972, Dr. David T. Carr from the Mayo
Clinic, USA, introduced the idea of forming an international
organization to continue this fruitful exchange of ideas, and
generally enthusiastic support for the concept was voiced by
those present at the workshop.
An organizing committee was formed and Dr. David T.
Carr accepted chairmanship of a committee to prepare a
constitution and bylaws. Dr. Oleg S. Selawry, with the
assistance of Drs. Lawrence Broder and George Higgins from
the Washington V.A. Hospital, USA, and other members of
the organization committee began the slow task of develop-
ment. Questionnaires and applications were sent to a wide
variety of individuals with interest in the problem of lung
cancer throughout the world, as well as to those who had
attended the Airlie meeting. By mid 1974, approximately 250
individuals had accepted membership in the Association and
plans were made to have an organization meeting in conjunc-
tion with the XIth International Cancer Congress, sponsored
by the UICC in Florence, Italy.
On the evening of October 26, 1974, in Florence, Italy,
the first formal organizational meeting was held under the
Chairmanship of Dr. Oleg S. Selawry. Bylaws of the Orga-
nization were discussed and adopted by unanimous vote. Dr.
Clifton Mountain, M.D. Anderson Hospital, Houston, USA,
presented the slate of officers and board of directors with
results of the ballots which had been mailed out prior to the
meeting. This slate of officers was unanimously elected.
A formal meeting of the Executive Committee was held
on December 11, 1974, in Key Biscayne, Florida, and many
subsequent informal meetings and discussions were held
concerning development and goals for the Association. The
Association was incorporated as a non-profit corporation.
Membership certificates were designed, with the now familiar
logo, prepared and mailed to all members. Periodic newslet-
ters were prepared and disseminated to inform membership of
organizational progress. Much of this work was done by Dr.
Lawrence Broder, first Secretary of the Association.
Early in 1976, Dr. Selawry assumed a new position at
the Miami Cancer Center and found it impossible to devote
sufficient time to the developing organization and submitted
his resignation in May of 1976. In Accordance with the
Bylaws, the Vice-President, David T. Carr, assumed the
office of President.
With this slow and somewhat tentative beginning, a
solid foundation for the Organization had been established.
Under the energetic leadership of Dr. Clifton Mountain, plans
were made for the First World Congress on Lung Cancer,
sponsored by IASLC. This highly successful conference was
held in May of 1978, at Hilton Head, South Carolina, with
large attendance by participants from throughout the world.
Contributing greatly to the success of this meeting was Dr.
Ronald Vincent, who served as Chairman of the conference.
Now officers and directors were elected to serve during the
period between 1978 and 1980. During this period, under Dr.
George A. Higgins’ leadership, there was a substantial in-
crease in membership. Newsletters were regularly distributed
and plans were made for the Second World Conference.
Under the chairmanship of Dr. Heine H. Hansen, the
Second World Conference on Lung Cancer was held on June
9 to 13, 1980, in Copenhagen, Denmark, and Malmoe, Swe-
den. Over 1000 participants from throughout the world at-
tended this highly successful conference. At the conclusion of
the meeting, the officers and directors were elected for 1980–
82.
Tokyo was chosen at the site of the Third World
Conference on Lung Cancer, to he held May 17 to 20, 1982.
Under the able guidance of Dr. Shichiro Ishikawa, Congress
President, and the energetic assistance of Congress Vice
President, Yoshihiro Hayata, the successful Third World
Conference was attended by over 15000 participants repre-
senting most of the major nations of the world.
Decision was made to hold the International World
Conference on Lung Cancer at three-year intervals instead of
two years. Toronto was selected as the site for the Fourth
International Conference on Lung Cancer with Dr. Ronald
Feld serving as Secretary-General and Dr. Ronald Ginsberg
as Chairman of the Program Committee.
The Fourth International Conference on Lung Cancer
was held in Toronto in August of 1985, had an outstanding
program of scientific content. One thousand participants reg-
istered for the conference, representing 33 nations. During
this conference, some new actions were approved by the
officers and the board of the Association. First, aggressive
development of workshops and conferences to take place
between world conferences; second, the format of a quarterly
journal to be sponsored by the IASLC; and third, authoriza-
tion was given to expand the business office of the association
in Copenhagen, Denmark, in order to improve communica-
tion and develop the journal Lung Cancer. Finally, Interlaken,
Switzerland, was chosen to host the 1988 conference, with
Dr. Rudolf Joss as Secretary-General and Chairman of the
Program Committee.
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The Fifth World Conference on Lung Cancer, Inter-
laken 1988, was again very successful. Officers and directors
were elected and Dr. Heine H. Hansen commenced his period
of presidency. Melbourne, Australia, was chosen as the loca-
tion of the 1991 World Conference, with David R. Ball as
Chairman and Secretary-General.
The Sixth World Conference on Lung Cancer was
attended by 1240 delegates from 47 countries and the first
recipient of the IASLC Merit Award was to be found. It was
decided that the award should be given to a person who had
been an IASLC member for at least 10 years, had manifested
himself/herself at an international level as a person engaged
in the field of lung cancer, either preclinically or clinically,
and had promoted the activities of the IASLC. It was unan-
imously agreed that the first recipient of the IASLC Merit
Award should be Dr. Clifton Mountain.
Colorado Springs, USA, was chosen as the location for
the 7th World Congress with Dr. Paul A. Bunn, Jr. as
Secretary General. At the same time, Dr. Yoshihiro Hayata
began his period as President, and Dr. Heine H. Hansen was
elected Executive Director for the expanding IASLC Office
located in Copenhagen. New activities were planned with a
series of workshops, now also including Eastern Europe and
South Africa. With the support from the industry, travelling
and educational grants within the Organization were created
for promising young investigators and colleagues from de-
veloping countries.
The Seventh World conference was a gigantic success
scientifically, socially, and economically. Set in beautiful
Colorado Springs, the meeting was attended by 1347 partic-
ipants from 49 countries. The IASLC Merit Award was
shared by Dr. Y. Shimosato and Dr. N. Bleehen. Seven more
awards were given, including Developing Nations awards
and Young Investigator awards. IASLC Recommendations
on Tobacco Policy were established, and Dr. Paul A. Bunn,
Jr., commenced his period of presidency. Dublin, Ireland,
was chosen as the venue for the 8th World Conference with
Dr. Desmond N. Carney as Secretary General.
After the Colorado meeting, several workshops were
held on topics ranging from prevention to tumor biology.
Also, the important and successful central European Lung
Cancer Conferences continued with meetings in Prague,
Czech Republic and Gdansk, Poland.
The 8th World Conference in Dublin took place in
August 1997. Dr. Desmond N. Carney and his staff had put
together an exciting and varied programme of science and
entertainment. With the attendance of 2505 delegates from 63
countries, and a surplus which enabled IASLC to expand its
activities during the next 3-year period, the Dublin meeting
was a truly memorable event in the history if IASLC. The
IASLC Merit Award was given to Dr. Heine H. Hansen,
Copenhagen, in recognition of his longstanding contributions
to the IASLC and the Mary J. Matthews Award was given to
Dr. William D. Travis, Washington DC, for his excellence in
lung cancer pathology.
Between the World Conferences in Dublin and Toyko,
a total of 13 workshops, symposia, and other meetings were
arranged under the auspices of IASLC, and 5 meetings were
arranged under the Educational Programme in India, Thai-
land, China, Brazil and Jordan with speakers from the IASLC
Facility.Under the chairmanship of Dr. Peter Goldstraw, UK,
the IASLC Staging Committee launched in 1999 the cumber-
some work of creating a new staging system for lung cancer
based on a truly international data register.
The 9th World Conference was held in Toyko, Japan in
September, 2000 with Dr. Y. Hayata as the Congress Presi-
dent. A total of 1130 abstracts were submitted to the Confer-
ence, which was attended by 2135 participants from 64
countries. Among the memorable events were the opening
ceremony, attended by members of the Japanese imperial
family, and the gigantic ball with traditional Japanese per-
formers that made a superb conclusion to the conference. The
IASLC Merit Award was given to Dr. Desmond N. Carne,
Ireland, for his outstanding contribution to the IASLC; the
Mary J. Matthews Award was given to Dr. Y. Shimosato,
Japan, for his life long achievements in the field of pathology,
and the Bristol-Myers Squibb Award was given to Daniel C.
Ihde, U.S.A., for his dedication to lung cancer research and
his support of IASLC and its aims. Dr. Harubumi Kato, Japan
took over the Presidency and Dr. Franses Shepherd, Canada
was chosen as the new President-Elect.
The Board decided on the Tokyo Declaration as an
official IASLC document requesting governments worldwide
to take actions against the alarming rate at which lung cancer
is occurring in both men and women. The Tokyo Declaration
is published in this Directory on page 11.
The first IASLC/CRFA Prevention Fellowship Award
was presented in Tokyo to Dr. Jun Zhang, China and in the
spring of 2001, two more Prevention Fellowship grants were
awarded to Dr. Yunfei Wang, USA and Dr. Fred R. Hirsch,
Denmark. Thanks to the energetic work of the President of
CRFA, Carolyn Aldige, three more grants have been secured.
The IASLC Textbook of Lung Cancer, which was
published in 1999, has now been translated into Chinese
thanks to the efforts of Dr. Li Hou-wen, Shenyang, China.
In 2001, workshops and symposia have been arranged
in Barcelona, Spain; in Prague, Czech Republic; in Reykja-
vik, Iceland, and in Chicago, USA. Under the IASLC Edu-
cational Programme, meetings and courses have been ar-
ranged in Dalian, China; in Istanbul, Turkey; in Bialystok.
Poland and in Beijing, China.
The Vancouver Trade and Convention Centre was the
venue for the 10th World Conference of Lung Cancer held in
August 2003 and chaired by Nevin Murray. There were a
total of 3344 registrants from 77 countries and 1149 abstracts
were submitted. Awards presented by IASLC president Ha-
rubumi Kato included: the IASLC Merit Award to Paul A.
Bunn, Mary Matthews Pathology Award to Adi Gazdar, BMS
IASLC Distinguished Achievement Award to Paul van
Houtte and The IASLC Distinguished Service Award to
Heine H. Hansen. The closing gala dinner hosted 2500
delegates with entertainment by “Cirque Pacifique”. The
Vancouver meeting maintained the tradition that IASLC
conferences grow in size and academic content without com-
promise of an atmosphere of international collegiality.
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The new International Convention Center of Barcelona,
located in the heart of a new activity area of Barcelona on the
shores of the Mediterranean, was the venue for the 11th
World Conference on Lung Cancer, chaired by Rafael Rosell
and Laureano Molins. This was the largest World Conference
yet, with a total of 4987 registrants from 92 countries and
1488 submitted abstracts. For the first time, a special Fellows’
Day was scheduled in conjunction with the conference, en-
compassing topics that were appealing and useful to younger
investigators. The main program of the conference included
87 sessions, with lectures given by 175 invited speakers and
almost 500 contributors to the scientific program. IASLC
awards included: the IASLC Merit Award to Harubumi Kato;
the Mary Matthews Award to Elisabeth Brambilla; the
IASLC Joseph Cullen Award to Nigel Gray; and the IASLC
Scientific Award to Thierry LeChevalier. Ten Young Inves-
tigator Awards and ten Developing Nation Awards were also
presented to outstanding delegates. The conference was a
unique occasion for investigators from several disciplines to
share their views on lung cancer research and join forces to
create a useful approach to lung cancer management.
12th World Conference on Lung Cancer. The 12th
IASLC World Conference took place at the COEX Conven-
tion Center in Seoul, Korea on September 2–6, 2007. The
conference theme was “Let’s Make Lung Cancer History”.
The conference’s main objectives were to:
Y Provide a forum for a world free of tobacco-related
cancer
Y Provide a multidisciplinary forum to share the advance-
ments in lung cancer prevention, diagnosis and treat-
ment
Y Disseminate scientific advances in lung cancer biology
and pathogenesis into clinical practice
Y Encourage new clinical trials based on recent progress in
molecular studies of lung cancer
Y Support the career development of fellows and junior
faculty in lung cancer
The meeting had 4769 registered delegates plus 112
accompanying person registrations for a total of 4881 persons
from 84 countries. A total of 1294 abstracts in eleven cate-
gories were submitted to the 12th World Conference of Lung
Cancer from 68 countries.
Scientific highlights: The program included 4 plenary
sessions (Tobacco or Health; Advances in Staging; Advances
in Management of NSCLC; Presidential Symposium), 20
mini symposia, 24 Meet-the-Professor-Sessions, 21 Educa-
tion Sessions, 2 Highlight of the Day Sessions and 15 Satel-
lite Symposia. Four best abstracts were presented at the
Presidential Symposium. Twenty-eight proffered paper ses-
sions and six Poster Discussions were held and 210 oral
papers and 144 poster discussion papers were presented.
During three general Poster Display Sessions, 724 abstracts
were shown.
IASLC Merit Award 2007 was given to Peter Gold-
straw, MD, FRCS in recognition of his scientific and organi-
sational leadership through many years. As a chair of the
IASLC Staging Project since 1998, has lead to the collection
of data over 100,000 cases treated by all modalities across the
globe and it has guaranteed the IASLC a major role in
formulating the 7th edition of the TNM classification for lung
cancer. The Mary Matthews Award 2007 was given to Fred
R. Hirsch, MD, PhD for his outstanding contributions to lung
cancer research. Dr. Hirsch initiated the Pathology Commit-
tee within IASLC in 1983 and he has authored more than 200
scientific publications on lung cancer and is Editor of 10
international textbooks in oncology in general and on lung
cancer in particular. Joseph Cullen Award 2007 was given to
Dr. James L. Mulshine, MD. Dr. Mulshine has been working
with a range of organizations to accelerate the use of high
resolution spiral CT in the quantitative evaluation of drung
response for early lung cancer over the last few years. IASLC
Scientific Award 2007 was given to Dr. Frances Shepherd,
MD, FRCPC. Dr. Shepherd has been instrumental in estab-
lishing Lung Cancer Tumor Banks in order to perform cor-
relative science studies pertaining to lung cancer. Through
her leadership, she has brought together a team of basic and
clinical researchers committed to the evaluation of molecular
pathways in lung cancer. This team is recognized world-wide
as one of the foremost groups of bench to beside research
pertaining to lung cancer. And Young Investigators Awards
and Developing Nations Awards are given to ten junior
scientists for each. Dan Idhe Lectureship, Bob Ginsberg
Lectureship and Heine Hansen Lectureship is given to three
abstracts.
Social Events: The opening Ceremony combined wel-
coming addresses from Prime Minister of Korea and IASLC
president with Korean drumming and other traditional musi-
cal performances. The closing gala dinner was held at COEX
Convention Hall. Hanbok (the Korean traditional costume)
Fashion show and musical entertainment, Ballroom Dance
were featured and attracted attention from international del-
egates. It was the time for all the delegates to relax and enjoy
a fusion of Korean and Western foods and entertainment.
Over the 3,000 registrants enjoyed.
One of the worthwhile achievements of the 12th WCLC
is the revision to the Tobacco Declaration. At the 12th
WCLC, IASLC added an article of “In order to help achieve
its goal of eliminating lung cancer, IASLC requests govern-
ment to initiate legislative action for ultimate elimination of
manufacture and sales of tobacco products.”
The 13th World Lung Cancer Conference will be held
in San Francisco, July/August, 2009. Drs. David Gandara and
David Jablons are the conference co-chairs.
The 14th World Lung Cancer conference will be held
in Amsterdam, The Netherlands, July 2–7, 2011. Dr. Pieter
Postmus is the Conference chairman. ICS (International
Conference Service), Vancouver, Canada has been chosen
to arrange the coming World Conference 2007, 2009, and
2011.
The new IASLC Journal “Journal of Thoracic Oncol-
ogy” started January 1, 2006 and published 9 issues in 2006.
It published 12 issues in 2007, 2008 and 2009. Dr. James Jett
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is the Editor of the JTO and has seen the JTO off to a very
successful start.
In 2002 Workshops, Symposia and Educational meet-
ings have been arranged in Belgium, Italy, Austria, India,
Taiwan.
In 2003 Workshops, Symposia and Educational meet-
ings have been arranged in Lithuania, China, Spain.
In 2004 IASLC arranged eight workshops, symposia
and educational meetings in Portugal, US, Switzerland, Thai-
land, Brazil, Poland and Germany.
In 2005 IASLC arranged eight workshops, symposia
and educational meetings in the UK, Japan, India, Indonesia,
Russia, China, Turkey and US.
In 2006 the IASLC arranged 11 workshops in Ireland,
US, Mexico, Czech Republic, Australia, Italy, China, Turkey
and Italy.
In 2007 the IASLC arranged 5 workshops in Ireland,
Italy, US, Turkey, Spain, Austria.
In 2008 the IASLC arranged 7 workshops in US,
Thailand, Switzerland, UK, Australia, Germany.
In 2009 the IASLC arranged 10 workshops in Ireland,
US, Belgium, France, India, Turkey, Brazil.
In 2008 two new initiatives began. In April: IASLC
and ESMO jointly arranged 1st European Lung Cancer
Conference in Geneva, Switzerland and in November 2009
the IASLC, ASTRO, ASCO and University of Chicago
arranged the 2008 Multidisciplinary Symposium in Tho-
racic Oncology in Chicago. Seven workshops in US, Thai-
land, Switzerland, UK, Chile and India were sponsored by
the IASLC. The Latin American Lung Cancer Conference
was held in Vina del Mar, Chile from October 9–10, 2008.
Dr. N. Yamaguchi was the chair of the meeting. The Asia
Pacific Lung Cancer Conference was held in Hyderabad,
India from December 5–7, 2008. Dr. P. Parikh was the
chair of the meeting. Seven workshops in US, France,
Brazil, India, UK and Turkey are planned to be sponsored
by IASLC in 2009.
The 15th World Conference on Lung Cancer will be
held in Sydney, Australia on October 27–November 1, 2013.
Dr. Kwun Fong is the Conference Chairman.
The 16th World Conference on Lung Cancer will be
held in Denver, Colorado, US in September 2010. Dr. Fred R.
Hirsch is the Conference Chairman.
The JTO is listed in pubmed Spring 2007 and will
receive its first impact factor in 2009. Manuscript submission
increased from 300 in 2006 to 600 in 2008. Manuscript
submissions have gone from 310 in 2006 to 779 in 2009. In
2009 we received our first full impact factor of 3.5 which is
considered excellent for a new journal.”
The first-ever site-specific guides on the updated TNM
classification of thoracic malignancies were published in
2009 by the IASLC with support from Editorial Rx Press.
The Staging Manual (print and CD) and Handbook in Tho-
racic Oncology, Peter Goldstraw, FRCS, Executive Editor,
were produced in association with the UICC and AJCC and
coordinated with publication of the 7th editions of the TNM
Classification of Malignant Tumors/UICC and AJCC Cancer
Staging Manual. The IASLC publications include IASLC-
original illustrations (IASLC Nodal Chart, Visceral Pleural
Invasion, and TNM Atlas of Illustrations). In addition to the
Manual and Handbook, the new thoracic oncology staging
information is also available in reference card and poster
formats. IASLC members received special discounted pricing
for these publications and products.
A 35-year history of the IASLC was also published in
2009, with Heine Hansen, MD, Editor. Following its an-
nouncement at the 2009 WCLC, IASLC members received a
complimentary copy.
SUMMARY OF THE 13TH WORLD
CONFERENCE ON LUNG CANCER
The 13th IASLC World Conference, held at the MosconeWest Convention Center in San Francisco and co-
chaired by Drs. David Jablons and David Gandara, can be
considered a great success by any measure: the largest
attendance ever at this event (6,215 attendees), the broad-
est representation from different counties (delegates from
85 different countries), the largest number of submitted
abstracts (1531), over 300 speakers and the largest number
of satellite symposia (13) ever at a World Conference.
Record attendance at the Young Investigators Symposium
exceeded all expectations, with 420 attendees from around
the world.
Scientific Highlights: The Opening Ceremony was
highlighted by an address from John Niederhuber, Director
of the US National Cancer Institute. The Scientific Pro-
gram featured an expanded number of simultaneous ses-
sions, designed to facilitate wide participation and inter-
action among attendees. The Program included 3 plenary
sessions (Personalized Therapy, State of the Art and Im-
plementation of IASLC Revised Staging System) and a
Presidential Symposium featuring 4 of the best submitted
abstracts, covering the breadth of basic and clinic research
represented within IASLC membership.
IASLC Merit Award is given to a member of IASLC,
who has made an extraordinary contribution to the organiza-
tion’s development (Dr. Giorgio Scagliotti). IASLC Scientific
Award is given to an IASLC scientist for life-time scientific
contribution in thoracic malignancy research and who has
also contributed to the organization’s development Dr. Bruce
Johnson and Dr. Thomas Lynch). Mary J. Matthews Award is
given to an IASLC scientist for life-time scientific achieve-
ments in pathology-translational research of thoracic malig-
nancies (Dr. Masayuki Noguchi). Joseph W. Cullen Award is
given to an IASLC scientist for life-time scientific achieve-
ments in prevention research of thoracic malignancies (Dr.
Stephen Lam).
Attendees to the 13th World Conference on Lung
Cancer were treated to an exciting Social Program, including
an Opening Ceremony, Welcome Reception and optional
Gala Dinner. Both the Opening Ceremony and Welcome
Reception were inclusive with Full registration. Tickets for
the Gala Dinner, featuring a performance by The Beach
Boys, for registered attendees and registered accompany-
ing guests.
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The conference also held a President’s Reception and
Faculty Dinner by invitation only. A complimentary Social
Excursion was offered during the 13th World Conference
on Lung Cancer which provided delegates a chance to
discover the beauty of San Francisco’s natural setting, fabu-
lous foods, world-class venues and diverse cultural heritage.
Complimentary Social Excursions took place. Delegates were
provided with four (4) tour options in which they could
participate. The social aspect is an integral part of the IASLC
World Conference. Attendees, exhibitors and speakers en-
joyed the opportunity to catch up with their peers, make new
contacts and network throughout the program.
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